These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Levetiracetam in pediatrics. Vigevano F J Child Neurol; 2005 Feb; 20(2):87-93. PubMed ID: 15794171 [TBL] [Abstract][Full Text] [Related]
4. Levetiracetam: treatment in epilepsy. Ben-Menachem E Expert Opin Pharmacother; 2003 Nov; 4(11):2079-88. PubMed ID: 14596661 [TBL] [Abstract][Full Text] [Related]
5. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate. Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398 [TBL] [Abstract][Full Text] [Related]
7. Concerns with antiepileptic drug initiation: safety, tolerability, and efficacy. Ferrendelli JA Epilepsia; 2001; 42 Suppl 4():28-30. PubMed ID: 11564122 [TBL] [Abstract][Full Text] [Related]
8. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study. Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011 [TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy. Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400 [TBL] [Abstract][Full Text] [Related]
10. Three new drugs for epilepsy: levetiracetam, oxcarbazepine, and zonisamide. Leppik IE J Child Neurol; 2002 Jan; 17 Suppl 1():S53-7. PubMed ID: 11918464 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy. Li S; Cao J; Xiao N; Cai F J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208 [TBL] [Abstract][Full Text] [Related]
13. Levetiracetam: a different approach to the pharmacotherapy of epilepsy. Welty TE; Gidal BE; Ficker DM; Privitera MD Ann Pharmacother; 2002 Feb; 36(2):296-304. PubMed ID: 11847952 [TBL] [Abstract][Full Text] [Related]
15. An assessment of levetiracetam as an anti-epileptic drug. Jain KK Expert Opin Investig Drugs; 2000 Jul; 9(7):1611-24. PubMed ID: 11060765 [TBL] [Abstract][Full Text] [Related]
16. Intravenous levetiracetam in children with seizures: a prospective safety study. Ng YT; Hastriter EV; Cardenas JF; Khoury EM; Chapman KE J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804 [TBL] [Abstract][Full Text] [Related]
17. Newer therapies in the drug treatment of epilepsy. McAuley JW; Biederman TS; Smith JC; Moore JL Ann Pharmacother; 2002 Jan; 36(1):119-29. PubMed ID: 11816240 [TBL] [Abstract][Full Text] [Related]
18. [Experience with levetiracetam in childhood epilepsy]. Neuwirth M; Saracz J; Hegyi M; Paraicz E; Kollár K; Móser J; Rosdy B; Herczegfalvi A; Fogarasi A Ideggyogy Sz; 2006 May; 59(5-6):179-82. PubMed ID: 16786712 [TBL] [Abstract][Full Text] [Related]
19. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study. Delanty N; Jones J; Tonner F Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371 [TBL] [Abstract][Full Text] [Related]
20. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study. Wheless JW; Clarke D; Hovinga CA; Ellis M; Durmeier M; McGregor A; Perkins F J Child Neurol; 2009 Aug; 24(8):946-51. PubMed ID: 19264738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]